Loading...

Aadi Bioscience, Inc.

AADI•NASDAQ
Healthcare
Biotechnology
$2.05
$-0.05(-2.38%)
U.S. Market is Open • 11:18

Aadi Bioscience, Inc. (AADI) Stock Overview

Explore Aadi Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap94.9M
P/E Ratio-61.60
EPS (TTM)$-2.36
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

AADI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aadi Bioscience, Inc. (AADI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -61.60 and a market capitalization of 94.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
21.30%
1-Month Change
-2.38%
3-Month Change
-31.21%
6-Month Change
-4.65%
Year-to-Date (YTD) Change
-34.71%
1-Year Change
12.64%
3-Year Change
-86.82%
5-Year Change
-76.30%
All-Time (Max) Change
-97.72%

Contact Information

https://aadibio.com
424 473 8055
17383 Sunset Boulevard, Pacific Palisades, CA, 90272

Company Facts

530 Employees
IPO DateFeb 16, 2018
CountryUS

Frequently Asked Questions